AIM ImmunoTech (AIM) Cost of Revenue (2010 - 2026)
AIM ImmunoTech (AIM) reported Cost of Revenue of $5,000 for Q2 2026, down 50.0% from $10,000 a year earlier but up 25.0% from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Cost of Revenue (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, AIM ImmunoTech's Cost of Revenue came in at $117,000, up 234.3% year-over-year; for FY2025, it was $128,000, up 312.9% from FY2024.
- Cost of Revenue has a five-year compound annual growth rate of -30.8% (FY2020 to FY2025).
- By year, Cost of Revenue came in at $31,000 in FY2024 (-26.2%), $42,000 in FY2023 and $850,000 in FY2021 (+5.5%).
- Five-year quarterly Cost of Revenue spans a low of $4,000 in Q1 2026 and a high of $176,000 in Q4 2021.
- Year over year, Cost of Revenue gained in four of the last eight quarters, with growth averaging 130.8%.
- The high point for year-over-year Cost of Revenue in five years was Q3 2025 (growth of 750.0%); the low point was Q2 2022 (a decline of 75.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4,000 (Q1 2026), $40,000 (Q4 2025) and $68,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Sep 30, 2025 | 68,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 30,000.00 |
| Jun 30, 2022 | 69,000.00 |
| Mar 31, 2022 | 77,000.00 |
| Dec 31, 2021 | 176,000.00 |
| Sep 30, 2021 | 157,000.00 |
| Jun 30, 2021 | 279,000.00 |
| Mar 31, 2021 | 237,000.00 |
| Dec 31, 2020 | 198,000.00 |
| Sep 30, 2020 | 204,000.00 |
API Access
AIM ImmunoTech Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();